ZNF217 and neoplasm: To determine how ZNF217’s oncogenic effects translate to an in vivo setting and to ascertain if ZNF217 exerts a dose-dependent effect on tumor progression, we derived luciferase-tagged OVCA420 cells that stably expresses low (ZNF217-Lo) and high (ZNF217-Hi) levels of FLAG-tagged ZNF217 (Fig. 5A).